Eventide Asset Management LLC has recently announced that it has increased stake in VectivBio Holding AG (NASDAQ:VECT) by 7.93%. After grabbing 3.68 million shares, the institutional investor is now in possession of 0.27 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 5.45% having worth around $38.56 million. Moreover, Driehaus Capital Management LLC increased its share by 51542.0 to have a control over 1.77 million shares. And Marshall Wace LLP raised its holdings to 0.3 million shares by acquiring 1.67 million shares or 2.48% of the stake.
VectivBio Holding AG (VECT) concluded trading on 05/25/23 at a closing price of $16.34, with 1.9 million shares of worth about $31.0 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 97.82% during that period and on Thursday the price saw a loss of about -0.06%. Currently the company’s common shares owned by public are about 62.74M shares, out of which, 59.92M shares are available for trading.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 5 analysts are covering the VECT stock and their offered price forecasts bring an average price target of $17.20. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $18.00 and could fall to a lowest price of $17.00. The stock’s current price level is 27.92% above of average price target set by the analysts, while a rise to estimated low would result in gain of 3.88% for the stock. However, touching the estimated high of $18.00 would mean a gain of 9.22% for the stock.
Eventide Healthcare & Life Scienc, Tekla Healthcare Investors, and Biotech Growth Trust Plc are the top 3 mutual funds which are holding stakes in VectivBio Holding AG Eventide Healthcare & Life Scienc is currently holding 3.41 million shares of worth totaling $35.73 million. The company recently came buying 1.07 million shares which brought its stake up to 5.05% of the company’s outstanding shares. Tekla Healthcare Investors sold 14104.0 shares, after which its hold over company’s outstanding shares shrunk to 0.82%, leaving 0.55 million shares with the mutual fund that have a worth of about $5.81 million. Biotech Growth Trust Plc, after buying 0.29 million shares, have now control over 0.44% of the stake in the company. It holds 532.0 shares of worth $3.08 million.
However, the stock later moved at a day high price of 16.60, or with a loss of -0.06%. Stock saw a price change of 48.55% in past 5 days and over the past one month there was a price change of 45.89%. Year-to-date (YTD), VECT shares are showing a performance of 88.57% which increased to 163.12% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.25 but also hit the highest price of $16.63 during that period. The average intraday trading volume for VectivBio Holding AG shares is 612.25K. The stock is currently trading 37.43% above its 20-day simple moving average (SMA20), while that difference is up 62.02% for SMA50 and it goes to 102.90% higher than SMA200.
Eventide Asset Management LLC acquired 3.68 million shares of VectivBio Holding AG having value of about $38.56 million. Data submitted at the U.S SEC by Eventide Asset Management LLC revealed that the firm now holds 0.27 million shares in the company valued at close to $4411800.0, or have control over 7.93% stake in the company. VectivBio Holding AG (NASDAQ: VECT) currently have 62.74M outstanding shares and institutions hold larger chunk of about 57.00% of that. Holding of mutual funds in the company is about 24.31% while other institutional holders and individual stake holders have control over 7.05% and — of the stake respectively.
The stock has a current market capitalization of $947.56M. It has posted earnings per share of -$1.87 in the same period. It has Quick Ratio of 9.10 while making debt-to-equity ratio of 0.05. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for VECT, volatility over the week remained 3.54% while standing at 6.26% over the month.
Analysts are in expectations that VectivBio Holding AG (VECT) stock would likely to be making an EPS of $Vector Group Ltd. in the current quarter, while forecast for next quarter EPS is $11.78 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $Veeco Instruments Inc. which is $VectivBio Holding AG at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $BEE VECTORING TECHNOLOGIES INTL in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 10.70%.
Analysts at 5 brokerage firms have issued recommendations for the VectivBio Holding AG (VECT)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.50. Out of those 5 Wall Street analysts, 1 recommended a “Buy” rating, while 4 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
